CIK: 0001609251 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 12, 2016
Total Value ($000): $277,542 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 275,248 | $29,154 | 10.5% | $136.10 | -18.0% | COM | 91307C102 |
| OM2 | ORTHOFIX INTERNATIONAL NV | 646,446 | $27,409 | 9.9% | $32.01 | — | COM | N6748L102 |
| — | IMPAX LABORATORIES INC | 730,817 | $21,062 | 7.6% | $33.19 | — | COM | 45256B101 |
| ENTA | ENANTA PHARMACEUTICALS INC | 906,930 | $19,998 | 7.2% | $37.63 | -30.4% | COM | 29251M106 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 396,545 | $19,918 | 7.2% | $58.35 | — | COM | 881624209 |
| — | AMGEN INC | 125,802 | $19,141 | 6.9% | $152.19 | — | COM | 31162100 |
| — | HALYARD HEALTH INC | 575,206 | $18,706 | 6.7% | $40.74 | — | COM | 40650V100 |
| — | SUCAMPO PHARMACEUTICALS-CL A | 1,631,398 | $17,896 | 6.4% | $12.18 | — | COM | 864909106 |
| — | INDIVIOR PLC | 4,727,970 | $15,800 | 5.7% | $3.34 | — | COM | G4766E108 |
| CNMD | CONMED CORP | 329,142 | $15,710 | 5.7% | $37.99 | +0.6% | COM | 207410101 |
| MRK | MERCK & CO. INC. | 257,538 | $14,837 | 5.3% | $39.26 | +0.6% | COM | 58933Y105 |
| — | RTI SURGICAL INC | 3,648,001 | $13,096 | 4.7% | $4.60 | — | COM | 74975N105 |
| — | SHIRE PLC-ADR | 63,166 | $11,628 | 4.2% | $184.09 | — | COM | 82481R106 |
| — | INVACARE CORP | 901,440 | $10,934 | 3.9% | $14.51 | — | COM | 461203101 |
| — | ALLERGAN PLC | 26,416 | $6,104 | 2.2% | $303.07 | — | COM | G0177J108 |
| — | DEPOMED INC | 217,904 | $4,275 | 1.5% | $16.75 | — | COM | 249908104 |
| — | AVIRAGEN THERAPEUTICS INC | 2,708,438 | $3,791 | 1.4% | $1.40 | — | COM | 53761102 |
| — | DERMA SCIENCES INC | 910,703 | $3,588 | 1.3% | $4.57 | — | COM | 249827502 |
| — | DIGIRAD CORP | 481,218 | $2,478 | 0.9% | $4.41 | — | COM | 253827109 |
| — | JUNIPER PHARMACEUTICALS INC | 287,755 | $2,017 | 0.7% | $9.19 | — | COM | 48203L107 |